Cyclerion Therapeutics

About:

Cyclerion Therapeutics harnesses the potential of soluble guanylate cyclase (sGC) pharmacology.

Website: https://www.cyclerion.com/

Twitter/X: Cyclerion

Top Investors: Invus, Polaris Partners, EcoR1 Capital, Pappas Capital, Lincoln Park Capital Fund

Description:

Cyclerion Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.